share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Hickey Benjamin

SEC announcement ·  Mar 13 05:49
Summary by Futu AI
On March 10, 2024, Benjamin Hickey, President of RayzeBio Org., engaged in a transaction involving the common stock of Bristol-Myers Squibb (BMY). Following the transaction, Hickey directly holds 780 shares of the company's common stock, each with a par value of $0.10. Additionally, there are 91 shares held indirectly by Hickey's spouse, bringing the total beneficial ownership to 871 shares. The nature of the indirect ownership is specified as being through the spouse. This transaction reflects changes in the holdings of a key individual within the company, which may be of interest to current and potential investors.
On March 10, 2024, Benjamin Hickey, President of RayzeBio Org., engaged in a transaction involving the common stock of Bristol-Myers Squibb (BMY). Following the transaction, Hickey directly holds 780 shares of the company's common stock, each with a par value of $0.10. Additionally, there are 91 shares held indirectly by Hickey's spouse, bringing the total beneficial ownership to 871 shares. The nature of the indirect ownership is specified as being through the spouse. This transaction reflects changes in the holdings of a key individual within the company, which may be of interest to current and potential investors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.